TuisSNPHF • OTCMKTS
add
Santen Pharmaceutical Co Ltd
Vorige sluiting
$11,40
Dagwisseling
$11,89 - $11,89
Jaarwisseling
$8,73 - $12,46
Markkapitalisasie
645,23 mjd JPY
Gemiddelde volume
48,00
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
TYO
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (JPY) | Jun. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 74,77 mjd | 3,29% |
Bedryfskoste | 29,61 mjd | -0,02% |
Netto inkomste | 10,63 mjd | 2,10% |
Netto winsgrens | 14,22 | -1,18% |
Wins per aandeel | — | — |
EBITDA | 17,86 mjd | 6,45% |
Effektiewe belastingkoers | 21,14% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (JPY) | Jun. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 89,74 mjd | 97,20% |
Totale bates | 434,16 mjd | 4,23% |
Totale aanspreeklikheid | 128,22 mjd | 10,24% |
Totale ekwiteit | 305,94 mjd | — |
Uitstaande aandele | 355,65 m | — |
Prys om te bespreek | 0,01 | — |
Opbrengs op bates | — | — |
Opbrengs op kapitaal | — | — |
Kontantvloei
Netto kontantverandering
| (JPY) | Jun. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 10,63 mjd | 2,10% |
Kontant van bedrywe | 12,14 mjd | 377,16% |
Kontant van beleggings | -1,02 mjd | 62,37% |
Kontant van finansiering | -18,94 mjd | -37,61% |
Netto kontantverandering | -4,84 mjd | 60,96% |
Beskikbare kontantvloei | — | — |
Meer oor
Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established. In 2014 Santen announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products. Wikipedia
Gestig
1890
Hoofkwartier
Webwerf
Werknemers
3 744
